Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Journal of Affective Disorders|July 5, 2021
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic reviewJason Ng, Joshua D Rosenblat, Leanna M W Lui, et al.Obesity (Silver Spring, Md.)|October 6, 2020
Antidepressant Medications and Weight Change: A Narrative ReviewHartej Gill, Barjot Gill, Sabine El-Halabi, et al.Journal of Affective Disorders|April 3, 2024
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic reviewGia Han Le, Sabrina Wong, Sebastian Badulescu, et al.Journal of Psychiatric Research|June 10, 2022
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysisYazen Alnefeesi, David Chen-Li, Ella Krane, et al.CNS Drugs|September 13, 2022
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewNiloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, et al.Journal of Affective Disorders|May 30, 2021
Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countriesYena Lee, Leanna M W Lui, David Chen-Li, et al.Journal of Psychiatric Research|June 28, 2022
Evaluating cognitive function in unaffected relatives of individuals with bipolar disorders: A meta-analysisEmily S Gillissie, Jillian R Krupski, Muhammad Youshay Jawad, et al.Journal of Affective Disorders|December 29, 2021
Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysisYuhan Karida Liu, Susan Ling, Leanna M W Lui, et al.Journal of Affective Disorders|June 23, 2021
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.Bipolar Disorders|May 15, 2020
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorderRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.Pageof 9